Impacted maxillary canine

K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K01.12 Hospital discharge: ICD-10 — K01.12 Cause of death: ICD-10 — K01.12 3 out of 7 registries used, show all original rules.	329
4. Check minimum number of events None	329
5. Include endpoints None	329
6. Filter based on genotype QC (FinnGen only)	329

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	K0112
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K0112
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K0112
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Impacted maxillary canine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11074	6671	4385
Only index persons	10022	6005	4017
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.12
Only index persons	0.19	0.22	0.15
Median age at first event (years)
Whole population	12.51	12.38	12.64
Only index persons	12.80	12.73	12.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	329	236	93
Unadjusted period prevalence (%)	0.07	0.08	0.04
Median age at first event (years)	14.89	14.51	15.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
287: Matched controls
2868

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

+∞

323.0

287

ECA00

NOMESCO Finland

Surgical exposure of tooth

152.3

98.6

100

SJD10

NOMESCO Finland

Attachment of arrow to fixed orthodontisk device

6.6

39.1

120

280

SJD00

NOMESCO Finland

Removal or reattacment of arrow in fixed orthodontisk device

6.5

38.3

119

281

SBB10

NOMESCO Finland

Teeth copy

4.7

31.8

146

515

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

6.0

30.9

233

SJD20

NOMESCO Finland

Attachment of modifiable arrow of fixed orthodontisk device

6.1

29.2

200

SJC50

NOMESCO Finland

Removal of orthodontisk device with at least 7 brackets

5.5

27.4

230

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

12.5

25.2

SAA04

NOMESCO Finland

Special inverstigation of mouth

5.0

24.7

249

K01.0

ICD-10 Finland

Embedded teeth

12.0

24.7

SJD40

NOMESCO Finland

Fixation of ready made palatinal or lingual arrow

4.8

24.6

278

SJB00

NOMESCO Finland

Fitting of loose orthodontic device with user information

4.4

22.5

300

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

5.3

22.4

183

SXC05

NOMESCO Finland

Other oral or dental procedure

4.0

21.2

104

360

EBA00

NOMESCO Finland

Extraction of tooth

3.2

19.3

173

930

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

5.3

19.2

144

SAA03

NOMESCO Finland

Extended examination of mouth

3.0

15.8

208

1353

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

6.5

15.7

SJD30

NOMESCO Finland

Demanding attachment of arrow to fixed orthodontisk device

4.7

15.4

137

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

15.1

15.3

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

3.8

15.1

222

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.7

14.8

184

1135

SJC10

NOMESCO Finland

Orthodontic bandage in one tooth

3.8

14.4

213

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

3.4

14.3

282

EBA10

NOMESCO Finland

Surgical removal of tooth

3.2

13.6

310

EBA12

NOMESCO Finland

Complicated surgical removal of tooth

6.3

13.4

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

3.3

12.8

277

WX110

NOMESCO Finland

Local anesthesy

2.9

12.2

238

1793

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

2.8

11.8

392

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.3

11.6

230

K01.13

ICD-10 Finland

Retained canine with obstruction in the lower jaw

124.8

11.5

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

5.0

11.2

SJX10

NOMESCO Finland

Short check-up visit for orthodontisk therapy

2.6

10.5

419

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.8

9.3

258

K00.00

ICD-10 Finland

Hypodontia

4.8

8.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.1

8.5

157

1047

SAA01

NOMESCO Finland

Simple examination of mouth

2.4

8.0

236

1899

OIKK

NOMESCO Finland

2.4

7.9

340

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

3.0

7.8

166

SJC00

NOMESCO Finland

Bracket with fixed attachment

15.6

7.8

SJC40

NOMESCO Finland

Removal of orthodontisk device with at most 6 brackets

2.6

7.7

265

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

25.8

7.6

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

4.0

7.5

WZA90

NOMESCO Finland

Other doctors statement

2.1

7.4

114

696

K01.14

ICD-10 Finland

Retained premolar with obstruction in the upper jaw

+∞

7.3

SJD50

NOMESCO Finland

Production and attachment of palatinal or lingual arrow

4.1

7.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

7.0

131

857

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

2.9

6.9

154

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.9

6.9

151

1047

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

41.0

6.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

6.2

518

K07.23

ICD-10 Finland

Deep bite

2.6

6.2

198

SJE90

NOMESCO Finland

Finishing face of orthodontick therapy

6.3

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019150) Specific gravity of Urine by Refractometry

596

1.75

4.70

4.7

3.2

1.0

kg/l

0.40

(40761535) Cells panel - Urine sediment

149

2.35

4.61

3.6

3.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

129

926

1.65

4.47

4.7

3.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

139

1036

1.59

4.04

8.7

9.1

1.2

mmol/l

0.77

123

908

(3019060) Gas panel - Arterial blood

2.70

3.71

3.0

10.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

3.79

3.38

1.9

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

2.94

3.23

2.9

3.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

643

1.57

3.20

3.0

2.5

97.5

54.6

u/l

0.73

587

(3002032) Base excess in Venous blood by calculation

362

1.69

3.06

8.9

8.2

1.4

1.2

mmol/l

0.16

292

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

564

1.58

3.02

3.3

3.1

24.5

30.2

ng/l

0.25

277

(3015736) pH of Urine

128

992

1.48

2.88

3.7

3.1

—

(40768441) Liver Pathology biopsy report

4.53

2.81

1.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.19

2.67

2.0

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.67

2.59

2.6

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

136

1.99

2.59

1.0

1.1

4.2

9.1

u/ml

1.51

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

4.07

2.58

1.1

1.2

91.9

111.5

—

(3000330) Specific gravity of Urine by Test strip

108

2.11

2.58

2.9

2.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

166

1.89

2.55

9.9

11.9

14.1

14.4

kpa

0.11

161

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

166

1.89

2.55

9.9

11.9

5.1

kpa

0.05

160

(3003396) Base excess in Arterial blood by calculation

167

1.88

2.50

9.9

11.9

0.7

0.6

mmol/l

0.06

139

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

103

2.11

2.47

1.5

1.4

—

(44790049)

3.00

2.43

2.8

1.6

—

(44790048)

3.00

2.43

2.8

1.6

—

(44790047)

3.00

2.43

2.8

1.6

—

(44806118)

3.00

2.43

2.8

1.6

—

(3020891) Body temperature

2.48

2.40

2.4

4.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

4.18

2.37

1.1

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

701

1.46

2.34

4.1

3.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

135

1.92

2.29

1.0

1.1

1.7

0.7

u/ml

0.37

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.83

2.22

2.3

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.74

2.16

1.0

1.4

132.4

129.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.34

2.16

3.2

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

155

1.81

2.07

1.1

1.2

4.0

2.8

u/ml

0.16

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

148

0.33

2.05

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

148

0.33

2.05

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

148

0.33

2.05

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

148

0.33

2.05

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

3.38

1.97

2.9

2.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

426

0.58

1.97

3.4

3.3

3.2

4.4

e6/l

0.43

227

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.77

1.94

1.4

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.23

1.89

2.9

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.55

1.85

2.0

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

293

1.54

1.76

1.7

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

177

0.44

1.75

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

147

1245

1.33

1.75

4.5

3.4

0.0

estimate

0.00

270

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.42

1.69

2.0

1.6

—

(1761868) Lipid panel - Serum or Plasma

694

1.37

1.67

2.5

2.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2.29

1.65

4.5

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.61

1.62

1.4

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.04

1.59

1.2

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

145

1242

1.30

1.54

6.1

4.7

0.0

estimate

0.00

281

(3029937) Albumin [Presence] in Urine by Test strip

685

1.35

1.53

5.2

3.6

0.0

estimate

0.50

276

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.90

1.53

1.1

6.1

7.7

u/ml

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

154

1333

1.29

1.50

7.9

5.5

6.3

mmol/l

0.11

139

1200

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

356

1.44

1.49

3.6

4.4

984.7

914.3

ng/l

0.05

296

(3009261) Glucose [Presence] in Urine by Test strip

146

1256

1.29

1.49

4.6

3.5

0.0

estimate

0.00

276

(3000991) Gas panel - Venous blood

323

1.46

13.6

10.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.53

1.46

1.0

1.3

—

(44813793)

2.53

1.46

1.0

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.07

1.45

2.9

3.4

14.1

32.7

mu/l

0.72

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

439

0.65

1.44

3.0

3.1

2.0

1.1

e6/l

0.45

236

(40761536) Microorganisms panel - Urine sediment

258

0.56

1.38

4.0

3.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

200

1.55

1.38

5.3

5.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

631

1.33

1.38

4.7

5.0

—

(3042936) Bacteria identified in Isolate by Culture

276

1.47

1.37

2.2

2.0

—

(3000494) Fungus identified in Specimen by Culture

235

1.50

1.34

1.7

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

120

1022

1.27

1.29

9.0

6.3

8.6

10.2

umol/l

2.23

108

937

(3000492) Spirometry study

222

1.49

1.24

1.7

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

361

1.39

1.23

4.6

4.1

29.9

0.02

354

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.19

1.22

3.9

3.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.66

1.22

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

113

964

1.26

1.19

10.0

8.9

1.2

mmol/l

0.57

106

903

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

186

1680

1.25

1.18

4.2

4.3

37.3

38.0

mmol/mol

0.51

176

1570

(3010726) Horse dander IgE Ab [Units/volume] in Serum

134

1.61

1.17

1.0

1.1

4.1

5.8

u/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

125

1081

1.25

1.17

4.1

4.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.88

1.15

2.8

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

177

1.51

1.12

3.4

5.7

0.5

0.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

104

1.67

1.11

2.3

2.9

0.7

0.1

e6/l

0.75

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

332

1.38

1.11

1.7

2.4

24865.0

6799.5

u/l

0.48

117

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

280

1.40

1.10

2.6

3.0

17.9

23.1

1.52

254

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.97

1.09

1.6

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.40

1.09

1.2

1.1

—

(3044889) 12 lead EKG panel

117

1338

0.81

1.09

3.0

2.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

204

1.46

1.07

1.7

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.98

1.04

3.6

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

197

1805

1.23

1.04

3.1

1.2

mmol/l

0.63

186

1697

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

310

1.37

1.03

2.6

1.8

—

(42870588) Differential panel, method unspecified - Blood

960

0.79

1.03

13.5

7.6

—

(3045414) Leukocytes [Presence] in Urine

106

0.46

1.03

1.8

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

817

1.25

1.02

4.9

6.0

36.8

37.4

g/l

0.59

768

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

473

1.30

1.01

4.0

2.9

1.1

1.3

mg/l

0.19

333

(4094501)

2.02

1.00

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1.70

0.99

1.6

2.2

0.5

0.6

nmol/l

0.10

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

124

1.56

0.99

2.2

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

278

2653

1.31

0.98

14.1

10.6

20.4

21.0

mg/l

0.09

213

1882

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.98

0.0

2.6

—

0.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.98

0.0

2.6

—

0.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.97

0.0

2.6

—

0.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

1.96

0.97

1.3

7.4

6.5

g/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1.96

0.97

1.3

2.4

g/l

—

(4062490)

1.96

0.97

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1.96

0.97

1.3

0.5

0.4

g/l

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

386

1.32

0.95

13.0

9.8

1.3

1.2

mmol/l

0.47

366

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.91

0.94

1.0

1.1

—

0.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

266

0.66

0.94

1.2

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.74

0.94

3.8

1.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.77

0.91

2.1

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.77

0.91

4.6

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.93

0.89

2.9

1.1

—

(3003694) ABO and Rh group [Type] in Blood

106

925

1.22

0.88

1.5

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.84

0.86

1.0

1.2

—

(3013512) EKG study

466

1.27

0.85

3.5

3.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

929

0.82

0.83

2.2

2.6

—

(3021901) Oxygen saturation in Capillary blood

1.76

0.83

2.0

3.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

731

1.22

0.81

1.5

1.6

93.6

97.2

pmol/l

0.30

374

(3008898) HLA-B27 [Presence]

148

0.60

0.81

1.0

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

268

0.69

0.80

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

279

1.33

0.80

1.6

1.3

—

(3026008) Bacteria identified in Urine by Culture

752

1.21

0.79

2.7

2.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.4

—

(36304419) Bacteria [Presence] in Urine

704

0.80

0.79

3.1

3.6

—

(3018133) Calcium [Moles/volume] in Urine

1.78

0.76

4.2

2.6

2.9

2.1

mmol/l

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

231

0.68

0.76

1.8

2.4

102.4

32.3

u/l

0.76

188

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

219

1.36

0.76

2.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.62

0.76

4.3

2.0

—

(21494755) Public health laboratory ask at order entry panel

212

1.35

0.73

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

876

0.83

0.73

2.1

2.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.60

0.72

2.8

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

160

1.40

0.72

1.8

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1.61

0.69

1.0

1.1

0.0

0.8

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.86

0.68

1.0

2.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.53

0.67

18.0

16.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.80

0.66

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.80

0.66

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

1.60

0.65

4.1

15.9

1.2

1.1

mmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.73

0.64

1.2

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

322

0.76

0.63

1.6

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.57

0.63

1.4

1.3

—

(3022621) pH of Urine by Test strip

156

1.37

0.62

7.0

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

241

2511

0.85

0.62

3.7

—

(36660697) Celiac disease serology panel - Serum

374

1.24

0.61

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.58

0.61

1.0

1.5

—

10.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.60

0.0

1.1

—

(3018095) Leukocytes [#/volume] in Urine

923

0.85

0.60

3.7

4.3

500.4

77.7

e6/l

0.49

604

(3007164) IgA [Mass/volume] in Serum or Plasma

102

918

1.16

0.59

1.4

1.6

1.9

g/l

0.02

514

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

115

0.60

0.59

2.7

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.4

—

(40768446) Kidney Pathology biopsy report

0.00

0.58

0.0

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.50

0.58

1.4

1.1

—

(40768797) Stomach Pathology biopsy report

250

0.75

0.56

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.63

0.56

1.7

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

644

1.17

0.54

1.8

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

297

1.24

0.53

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

135

1.35

0.52

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.51

0.52

1.2

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

175

1647

1.13

0.52

7.8

6.1

83.8

87.9

u/l

0.55

162

1535

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

112

1027

1.14

0.49

1.5

1.7

1.0

1.9

u/ml

0.93

237

(3032080) INR in Blood by Coagulation assay

650

1.16

0.48

12.3

5.2

1.2

1.1

inr

0.51

237

(3002582) Erythrocytes [#/volume] in Urine

763

0.86

0.48

3.2

3.8

45.7

52.5

e6/l

0.08

567

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

155

1.31

0.48

18.8

16.3

1.3

1.1

mg/l

0.40

150

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

384

0.82

0.47

1.2

15.1

19.5

iu/ml

0.40

103

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.47

0.47

1.6

1.2

—

(40768443) Skin Pathology biopsy report

0.60

0.46

1.0

1.1

—

(3022145) Colonoscopy Study observation

197

0.75

0.45

1.3

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

976

0.88

0.45

2.0

2.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.38

0.44

6.7

12.3

64.6

68.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.62

0.43

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.62

0.43

1.2

1.1

—

(3011648) Oxygen content in Venous blood

1.62

0.43

8.4

17.0

11.2

12.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

333

1.19

0.43

13.4

8.4

0.8

mmol/l

0.48

313

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

149

1.29

0.43

1.6

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

600

0.86

0.42

8.6

5.4

88.5

90.4

0.24

591

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

158

1491

1.11

0.42

5.2

3.5

31.0

32.0

u/l

0.12

146

1418

(3019198) Lymphocytes [#/volume] in Blood

154

1452

1.11

0.42

9.6

7.2

2.0

e9/l

0.16

138

1286

(3000093) Morphology [Interpretation] in Blood Narrative

1.52

0.41

1.0

1.1

—

(4035726)

138

0.72

0.41

1.5

1.6

—

(4211845)

0.00

0.41

0.0

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.41

0.0

5.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.41

0.0

5.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

0.00

0.41

0.0

1.0

—

93.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3024928) Oxygen saturation in Venous blood

1.36

0.41

7.1

11.3

—

(4146454)

0.00

0.41

0.0

2.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

1.48

0.40

5.0

3.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.40

0.0

7.5

—

(40758558) Short blood count panel - Blood

711

0.88

0.40

8.2

7.2

—

(3019225) pH of Specimen

151

1.27

0.39

1.5

4.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.44

0.39

1.4

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.44

0.39

1.2

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

133

1.29

0.39

1.3

1.4

—

(40768804) Tissue Pathology biopsy report

740

0.88

0.38

1.5

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.39

0.38

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

342

0.83

0.38

1.6

1.5

—

(3011288) Drugs identified in Urine by Screen method

245

0.80

0.37

1.3

2.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

217

1.22

0.37

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

218

2104

1.11

0.36

4.1

3.7

14.5

pmol/l

0.05

193

1888

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.63

0.36

1.0

1.5

—

(3021589) Normoblasts [#/volume] in Blood

140

1324

1.10

0.35

10.4

9.6

0.0

e9/l

0.49

119

1054

(3013115) Eosinophils [#/volume] in Blood

150

1424

1.10

0.34

10.6

7.7

0.2

e9/l

0.12

132

1253

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

144

0.76

0.34

2.3

1.4

—

(3001604) Monocytes [#/volume] in Blood

146

1385

1.10

0.34

10.1

7.3

0.5

e9/l

0.17

128

1193

(3000963) Hemoglobin [Mass/volume] in Blood

299

3032

0.85

0.32

20.9

15.6

133.2

134.5

g/l

0.99

293

2978

(3001019) Free T4 and TSH panel - Serum or Plasma

1.32

0.32

1.1

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.35

0.31

1.9

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

175

1.21

0.31

3.0

2.1

7.2

9.4

iu/l

0.48

131

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

175

1.21

0.31

2.6

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

677

0.90

0.30

3.9

2.9

2.4

mmol/l

0.41

596

(3025941) Bacteria identified in Stool by Culture

152

0.78

0.30

1.6

1.2

—

(3023368) Bacteria identified in Blood by Culture

451

1.13

0.29

5.1

4.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.23

0.29

1.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.23

0.29

1.0

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

129

0.77

0.28

1.4

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

194

0.82

0.28

3.9

4.7

17.5

21.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.30

0.28

1.4

1.2

—

(3006315) Basophils [#/volume] in Blood

145

1385

1.08

0.28

10.2

7.3

0.0

e9/l

0.66

130

1192

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

200

1936

1.08

0.27

3.5

3.6

2.7

mmol/l

0.03

188

1805

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

362

0.87

0.27

1.2

20.3

7.6

u/ml

0.29

132

(3002256) Pathology report gross observation

214

0.83

0.27

1.0

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

1.20

0.26

1.4

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

0.67

0.26

2.2

1.7

0.2

0.3

nmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.26

0.26

1.6

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

283

1.14

0.25

13.5

6.3

1.5

1.1

mmol/l

0.34

207

(3037522) Nuclear Ab [Titer] in Serum

339

0.87

0.25

1.5

624.0

478.7

titre

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

197

1910

1.08

0.25

3.3

1.4

1.5

mmol/l

0.77

186

1790

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

223

0.84

0.25

1.2

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

178

1722

1.07

0.24

4.8

4.1

—

(3028707) Methadone [Presence] in Urine by Screen method

179

0.83

0.23

1.7

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.25

0.22

1.2

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

144

1.19

0.22

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.22

0.22

3.6

3.5

1.9

1.7

umol/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

199

1937

1.07

0.21

3.3

3.4

4.4

4.5

mmol/l

0.17

189

1823

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

154

1.18

0.21

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.00

0.21

0.0

1.7

—

263.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.0

—

1.5

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

39.3

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

33.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.21

0.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.4

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.21

0.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

107.8

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

0.8

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

278

1.13

0.21

1.4

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

686

1.08

0.21

2.5

2.7

2.9

2.7

mg/l

0.26

595

(3010813) Leukocytes [#/volume] in Blood

300

3031

0.88

0.21

20.3

15.5

6.8

6.6

e9/l

1.00

287

2918

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

4.5

—

10.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

6.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(40761511) CBC panel - Blood by Automated count

280

2761

1.09

0.20

12.3

9.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.20

0.0

2.0

—

(3006462) Nitrate [Presence] in Urine

0.00

0.20

0.0

2.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.20

0.20

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.20

0.20

1.5

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

173

1779

0.94

0.19

4.3

4.1

8.8

8.7

mm/h

0.03

163

1624

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.24

0.19

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

659

0.93

0.18

1.6

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

444

0.91

0.18

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

153

0.84

0.18

2.8

3.1

0.8

ug/l

—

105

(3044290) Cell count panel - Cerebral spinal fluid

1.21

0.18

2.9

3.0

—

(3037121) Protein [Mass/volume] in Urine

121

0.82

0.18

1.7

5.0

0.1

0.3

g/l

—

(3026361) Erythrocytes [#/volume] in Blood

300

3028

0.90

0.18

20.2

15.4

4.5

4.6

e12/l

0.98

288

2917

(3035941) MCH [Entitic mass]

300

3027

0.90

0.17

20.2

15.4

29.6

0.01

294

2972

(3024731) MCV [Entitic volume]

300

3027

0.90

0.17

20.2

15.4

88.4

0.06

294

2972

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

238

2420

0.94

0.17

4.7

4.2

1.9

mu/l

0.02

226

2241

(3028626) Oxygen [Partial pressure] in Capillary blood

225

1.12

0.16

8.8

6.4

9.9

9.8

kpa

0.10

217

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

151

0.86

0.16

2.2

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

227

1.11

0.14

1.5

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.77

0.14

2.1

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

412

1.08

0.14

4.0

4.5

7.4

12.9

mg/mmol

0.64

291

(3013650) Neutrophils [#/volume] in Blood by Automated count

161

1571

1.05

0.14

10.9

9.4

3.7

3.8

e9/l

0.10

140

1355

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

149

0.87

0.14

1.1

1.2

—

29.0

—

(3007461) Platelets [#/volume] in Blood

300

3023

0.91

0.13

20.2

15.5

271.6

262.9

e9/l

1.51

289

2923

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

123

1.14

0.12

1.7

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

494

1.06

0.12

2.2

2.9

148.4

82.7

ug/g

0.49

364

(3022313) Gas panel - Capillary blood

232

1.08

0.10

8.6

6.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

203

1.09

0.10

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1.15

0.09

1.7

1.5

0.1

0.0

iu/ml

—

(3016879) Cocaine [Presence] in Urine

321

1.07

0.09

1.4

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

321

1.07

0.09

2.8

3.3

397.2

410.4

ng/l

0.02

182

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

542

0.95

0.09

3.0

2.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.11

0.09

1.2

1.6

9.9

9.6

u/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

246

2436

1.04

0.08

16.3

11.7

139.4

139.6

mmol/l

0.36

236

2353

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.04

0.08

3.2

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.83

0.08

1.0

2.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.80

0.08

9.6

8.7

—

112.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

510

1.05

0.08

2.2

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

728

1.04

0.08

1.6

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.81

0.07

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

347

0.95

0.07

1.4

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.05

0.07

1.8

1.5

44.5

33.8

u/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.86

0.07

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.85

0.07

1.4

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.82

0.07

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.82

0.07

1.4

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

443

1.04

0.07

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1.11

0.06

1.9

2.4

28.9

45.4

u/ml

0.37

(4010399)

148

1.09

0.06

1.2

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

326

1.05

0.05

15.4

11.3

25.6

24.9

mmol/l

0.60

326

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

606

0.97

0.05

2.5

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

194

1957

0.98

0.04

9.8

8.9

95.6

100.0

ml/min/173m2

1.19

135

1404

(3018010) Neutrophils/100 leukocytes in Blood

135

1367

0.98

0.04

9.9

7.1

53.8

53.9

0.01

126

1297

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.10

0.04

1.8

2.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

116

1174

0.98

0.03

2.1

2.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

139

0.93

0.03

4.7

3.1

60.2

79.8

ml/min/173m2

—

(3006504) Eosinophils/100 leukocytes in Blood

130

1313

0.98

0.03

10.0

7.5

3.1

2.8

0.85

119

1235

(3020630) Protein [Mass/volume] in Serum or Plasma

108

0.92

0.03

1.9

2.4

69.5

64.5

g/l

—

102

(3028300) Cannabinoids [Presence] in Urine

349

0.97

0.02

1.4

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

690

1.02

0.02

2.8

2.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

103

1.07

0.02

1.4

1.7

—

(3027008) Opiates [Presence] in Urine

348

0.97

0.02

1.4

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

821

1.01

0.01

3.2

3.9

—

(3019069) Monocytes/100 leukocytes in Blood

132

1328

0.99

0.01

10.5

7.7

8.5

8.3

0.13

121

1260

(3031040) Bacteria [#/volume] in Urine by Automated count

167

1662

1.01

0.01

4.5

4.1

297.8

240.4

e6/l

—

(3018418) pH of Serum or Plasma

567

0.99

0.01

3.5

3.9

7.4

—

113

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

176

0.96

0.00

2.8

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

264

1.02

0.00

1.4

1.3

53.8

134.1

iu/ml

1.55

(3012516) Albumin [Mass/volume] in Urine

394

1.02

0.00

2.8

3.8

63.8

87.3

mg/l

0.23

278

(3009542) Hematocrit [Volume Fraction] of Blood

262

2626

0.99

0.00

15.7

11.9

37.9

39.7

2.13

197

2157

(3022096) Basophils/100 leukocytes in Blood

128

1274

1.01

0.00

9.9

7.7

0.6

0.10

117

1202

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

200

1994

1.01

0.00

3.4

3.1

5.5

5.6

mmol/l

0.46

189

1820

(3002030) Lymphocytes/100 leukocytes in Blood

139

1396

0.99

0.00

10.2

7.3

31.8

31.9

0.04

129

1323

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

178

1.01

0.00

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

259

2591

1.00

0.00

10.4

8.5

25.3

24.1

u/l

0.29

247

2485

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.04

0.00

1.5

1.8

—

(3027944) Amphetamines [Presence] in Urine

345

0.98

0.00

1.4

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

154

0.97

0.00

1.5

1.3

239.9

291.2

miu/ml

—

(3026782) Osmolality of Urine

485

1.01

0.00

2.4

3.3

585.5

589.7

mosm/kgh2o

0.04

414

(3023103) Potassium [Moles/volume] in Serum or Plasma

244

2435

1.01

0.00

16.3

11.7

3.9

mmol/l

0.91

233

2345

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

51.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

16.7

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

3.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

9.9

—

62.1

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

21.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.96

0.00

1.1

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.97

0.00

1.2

1.5

—

(3017704) Immunofixation for Urine

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.2

—

(3012565) Volume of 24 hour Urine

0.00

0.0

1.4

—

2005.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.9

—

10.9

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

9.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.0

2.2

—

4.8

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

27.3

—

0.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.98

0.00

1.4

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

600

1.00

0.00

4.7

3.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.4

—

312.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

18.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

110

1.00

0.00

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.0

2.2

—

9.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.0

1.9

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.92

0.00

1.4

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1616796) Gas panel - Central venous blood

0.88

0.00

2.2

5.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

3.6

—

57.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

3.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

58.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

8.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

85.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: K11_MAXIL_CANINE_FAILED_ERUPT_OBSTRUCTION_TOOTH – Impacted maxillary canine

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Impacted maxillary canine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints